Concepedia

Amy Visser

AV

Statistics

Publications

15

Citations

1.4K

H-Index

14

Active since

1968

Affiliations

The Netherlands Cancer Institute(Current)

Duke University

University of Toronto

Oregon Health & Science University

Amy Visser is an author at The Netherlands Cancer Institute specializing in life sciences, myasthenia gravis pharmacotherapy, and myasthenia gravis.

Publications per year

1968–2021

15

Publications

15

Safety, efficacy, and tolerability of efgartigimod in patients with generalised myasthenia gravis (ADAPT): a multicentre, randomised, placebo-controlled, phase 3 trial

James F. Howard, Vera Bril, Tuan Vu et al. · The Lancet Neurology · 2021 · 668 citations · Full text

Medicine, Endocrinology, Pharmacotherapy +4

Rituximab as treatment for anti-MuSK myasthenia gravis

Michael K. Hehir, Lisa D. Hobson‐Webb, Michael Benatar et al. · Neurology · 2017 · 248 citations

Pharmacy, Immunology, Pharmacotherapy +15

Thymectomy may not be associated with clinical improvement in MuSK myasthenia gravis

Katherine Clifford, Lisa D. Hobson‐Webb, Michael Benatar et al. · Muscle & Nerve · 2018 · 85 citations

Medicine, Immunology, Surgery +13

Studies on plasma membranes. VII. A leucyl-β-naphthylamidase-containing repeating unit on the surface of isolated liver and hepatoma plasma membranes

P. Emmelot, Amy Visser, E. L. Benedetti · Biochimica et Biophysica Acta (BBA) - Biomembranes · 1968 · 73 citations

Life Sciences, Biochemistry, Molecular Biology +12

Nusinersen in adult patients with spinal muscular atrophy

Orly Moshe‐Lilie, Amy Visser, Nizar Chahin et al. · Neurology · 2020 · 53 citations

Medicine, Neurological Surgery, Surgery +16

1–5 of 15